2020 Edition

Hungary’s First Steps into Digital Healthcare

After years of planning and collaboration with various stakeholders, in 2017 the Hungarian government launched the Electronic Health Service Area (EESZT): a centralized database of patient records and health interventions with the aim of bringing Hungary in…

How Hungary is Maintaining its Clinical Research Reputation

According to Peter Holchacker, director general of Hungary’s Association of Innovative Pharmaceutical Manufacturers (AIPM), “clinical trials initiated by multinational companies, represent, on average, an investment of approximately EUR 300 million…

Read the Full Version
Alternative Models of Industry-Academia Research Collaboration in Hungary

Hungary’s longstanding tradition of pharmacology is a major point of pride for the country’s scientists and researchers who today have hopes to elevate the country’s research environment to a region-leading position once more through new models of industry-academia collaboration.

Hungary: Entering a New Age of Patient Access?

In 2016, Hungary transitioned from a second-tier member to a full member of the EU. As Judit Bidló, deputy director general of pricing and reimbursement for Hungary’s National Institute of…

Four Companies to Know in Hungary

The pharmaceutical industry is one of the pillars of the Hungarian economy and has been identified as a key growth driver for the future by the government of  Prime Minister Viktor Orbán. Here, we highlight four Hungarian pharma champions and…

In Profile
Company Spotlight
Anna Wienner
general manager, IBSA Hungary

As general manager of the Hungarian affiliate of Swiss firm IBSA, Anna Wienner has proven herself to be a motivated pharma leader with particular expertise in reshaping and building organizations. Joining the company in 2015… 

Company Spotlight
The Nuclear Family

Established in 1997, Medi-Radiopharma is a Hungarian privately held company operating in the field of nuclear medicine, a specialized area of radiology that uses very small amounts of radioactive materials, or radiopharmaceuticals, to examine organ function and structure…

Thanks for reading!

The Digital Version of the Healthcare & Life Sciences Review: Hungary is available and optimized for desktop browsers.

Visit our website with your computer or download the pdf report

Read the Full Version

2020. Healthcare & Life Sciences Review was produced by Pharmaboardroom.

Copyright: All rights reserved. No part of this publication maybe reproduced in any form or by any means, whether electronic, mechanical or otherwise including photocopying, recording or any information storage or retrieval system without prior written consent of PharmaBoardroom. While every attempt is made to ensure the accuracy of the information contained in this report, neither PharmaBoardroom nor the authors accept any liabilities for errors and omissions. Opinions expressed in this report are not necessarily those of the authors. All the images belongs to its respective authors.

Report Coordinators: Joseph Kun, Manon Canicio
Report Assistant: Erik Vos
Senior Editor: Patrick Burton
Publisher: Mariuca Georgescu
Graphic Designer: Miriam León


Contact us

+44 20 7867 3717

For media inquiries, please contact:


PharmaBoardroom Limited Lynton House, 7-12, Tavistock Square, London, United Kingdom, WC1H 9LT